Health matters: obesity and the food environment
The researchers concluded that the relative risk was increased by no more than 31% for those on GLP-1 agonists
By enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and suppressing appetite, GLP-1R agonists (GLP-1RAs) have demonstrated efficacy in managing type 2 diabetes and obesity (23)
Beta-glucans have been studied for supporting immune activation and cytokine production, making PRALISUR a key addition to this formula for helping maintain normal immune function in dogs and cats at every life stage
Can I offer GLP-1 weight loss alongside my existing services
Additionally, spots accompanied by systemic symptoms such as unexplained weight loss, fatigue, difficulty swallowing, or a chronic sore throat are red flags that require immediate attention